Stock & Company Details
Fennec Pharmaceuticals Inc $FENC
Price:
N/A
N/A
35M
$381M
52 Week High:
N/A
10 Day Average Volume:
N/A
-38.46
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
FENC technical indicators
Latest Fennec Pharmaceuticals Inc (FENC) indicator readings as of 2026-10-29.
FENC's 14-day RSI is 56.6, in neutral territory. At $10.95 it is trading 19.1% above its 200-day moving average of $9.19, and below its 50-day average of $10.96. Price sits near the upper Bollinger Band ($9.86 to $10.96). ADX reads 21.5, sitting between trending and range-bound.
Overview
Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Finance Bot
Ask your questions
Start by typing a question below.
